A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
PHASE3
This is an open, randomized, controlled, multicenter Phase III clinical stu...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial
PHASE2
This study aims to conduct a prospective, multicenter, randomized controlle...
Status
Withdrawn
Location
Womens' Hosptial, School of Medicine, Zhejiang University